Summary
CME Group Inc. (CME) announced a significant leadership transition, with current Chairman and CEO Terrence A. Duffy transitioning to Executive Chairman and President and CFO Lynne C. Fitzpatrick succeeding him as Chief Executive Officer. This leadership change, effective on the later of March 1, 2027, or the filing of the 2026 10-K, aims to ensure leadership continuity and leverage Duffy's extensive experience in a strategic oversight role while elevating Fitzpatrick, a long-tenured executive with deep financial and operational expertise, to lead the company. The transition plan outlines specific arrangements for both executives. Mr. Duffy will continue as CEO until the transition date and then serve as Executive Chairman through December 31, 2027, with his compensation and benefits largely remaining consistent. Ms. Fitzpatrick will assume the CEO role and a board seat on the transition date, with a new compensation package including a $1.2 million base salary, a 200% target bonus, and a 700% long-term incentive opportunity. The company has also commenced a search for Ms. Fitzpatrick's successor as CFO.
Key Highlights
- 1Terrence A. Duffy to transition from CEO to Executive Chairman, effective March 1, 2027 (or later upon 2026 10-K filing).
- 2Lynne C. Fitzpatrick appointed as the new Chief Executive Officer, succeeding Mr. Duffy.
- 3Ms. Fitzpatrick will also be appointed to the Board of Directors and its Executive Committee upon assuming the CEO role.
- 4Mr. Duffy's role as Executive Chairman will extend through December 31, 2027, focusing on strategic oversight and transition facilitation.
- 5Ms. Fitzpatrick's new compensation package as CEO includes a $1.2 million base salary, 200% annual bonus target, and 700% long-term incentive target.
- 6CME Group will initiate a search for a successor to Ms. Fitzpatrick as Chief Financial Officer.
- 7The transition is designed to ensure continuity in leadership and strategic direction for the company.